⬆
✘
 
By continuing to use the site, you allow the use of Cookies and agree to the privacy policy.
.,о.,р..и.:г,.и.,н.;н.,а;,л.. .,н.:а,.х.,о.,д.;и.,т..с.:я,, ..н.;а., .,k;,i..b.:e,;r.,i.,s.,.;.r.:u,
⌂ /ICD-10 diagnoses /
 Share

T32 Corrosions classified according to extent of body surface involved

Add Analogs Compare
Found partially in the 57 (39) ⓘ✘Found partially in the 57 drugs (39 of these, according to Kiberis statistics) in 41 selected books (authors) ... hide
  Effect Influence Cases ⓘ ✘ Effect - how much the symptom improves in one treatment cycle on average. Example: drug Pain relief for cancer pain-Effectiveness (E) is high, but the effect (I) negative, because the patient will get worse over time.
Influence of the symptom on the outcome of the patient's treatment as a whole (i.e., the importance of the symptom). Example: menopause can not be cured (E low). But some means during menopause will be better than others (I high).
Cases - the number of investigated treatment results for a given complaint, on the basis of which the effect and effect were calculated. These cases have already passed automatic AI verification of data quality and reliability.
  • t32 corrosions classified according to extent of body surface involved
  •  63%+41%4 read Cicuta virosa
  •  61%+3%187 read Echinacea compositum sn
    Diseases - E 66% (I 8%, 187 cases.); Dependence - E 46% (I -2%, 14 cases.); Superficial - E 70% (I 2%, 15 cases.); The whole body - E 59% (I 3%, 94 cases.)
  •  60%+9%122 read China officinalis
    Diseases - E 51% (I 10%, 122 cases.); Superficial - E 68% (I 4%, 7 cases.); The whole body - E 61% (I 12%, 61 cases.)
  •  56%+14%48 read Cactus grandiflorus
    Diseases - E 53% (I 12%, 48 cases.); The whole body - E 58% (I 16%, 15 cases.)
  •  54%+1%23 read Engystol
    Diseases - E 66% (I 12%, 23 cases.); Superficial - E 75% (I 18%, 3 cases.); The whole body - E 19% (I -28%, 11 cases.)
  •  54%+13%15 read Iodum purum
    Diseases - E 55% (I 27%, 15 cases.); The whole body - E 52% (I -2%, 10 cases.)
  •  54%+26%16 read Camphora
  •  50%+6%15 read Sulphuricum acidum
    Diseases - E 41% (I 14%, 15 cases.); The whole body - E 58% (I -3%, 7 cases.)
  •  50%+4%142 read Crotalus horridus
    Diseases - E 65% (I 14%, 142 cases.); Dependence - E 33% (I -5%, 10 cases.); Superficial - E 55% (I 6%, 18 cases.); The whole body - E 44% (I 0%, 65 cases.)
  •  49%-1%25 read Ledum palustre
    Diseases - E 41% (I -5%, 25 cases.); The whole body - E 56% (I 2%, 14 cases.)
  •  49%-8%21 read Glonoinum
    Diseases - E 41% (I -10%, 21 cases.); The whole body - E 56% (I -7%, 11 cases.)
  •  48%+3%93 read Aconitum napellus
    Diseases - E 48% (I 11%, 93 cases.); Dependence - E 6% (I -31%, 8 cases.); Superficial - E 70% (I 13%, 7 cases.); The whole body - E 67% (I 19%, 32 cases.)
  •  48%+3%54 read Apis mellifica
    Diseases - E 61% (I 15%, 54 cases.); Dependence - E 11% (I -13%, 8 cases.); The whole body - E 70% (I 5%, 23 cases.)
  •  47%-6%9 read Psorinoheel n
  •  47%+5%209 read Arnica montana
    Diseases - E 62% (I 11%, 209 cases.); Dependence - E 33% (I 6%, 14 cases.); Superficial - E 43% (I 0%, 21 cases.); The whole body - E 49% (I 3%, 117 cases.)
  •  46%+3%20 read Ranunculus bulbosus
    Diseases - E 45% (I 10%, 20 cases.); The whole body - E 46% (I -5%, 16 cases.)
  •  46%+8%31 read Carboneum sulphuratum
    Diseases - E 50% (I 19%, 31 cases.); Superficial - E 44% (I 3%, 5 cases.); The whole body - E 43% (I 0%, 9 cases.)
  •  45%+4%43 read Ipecacuanha
    Diseases - E 47% (I 13%, 43 cases.); The whole body - E 43% (I -6%, 14 cases.)
  •  44%-2%27 read Iris versicolor
    Diseases - E 39% (I 2%, 27 cases.); The whole body - E 49% (I -7%, 19 cases.)
  •  44%+5%257 read Rhus toxicodendron
    Diseases - E 42% (I -1%, 257 cases.); Dependence - E 18% (I -8%, 31 cases.); Superficial - E 66% (I 18%, 31 cases.); The whole body - E 48% (I 9%, 160 cases.)
  •  43%+2%28 read Mezereum
    Diseases - E 31% (I -12%, 28 cases.); Superficial - E 46% (I 15%, 10 cases.); The whole body - E 50% (I 2%, 7 cases.)
  •  40%+10%9 read Bufo rana
  •  40%+7%435 read Arsenicum album
    Diseases - E 40% (I 7%, 435 cases.); Dependence - E 19% (I -3%, 35 cases.); Superficial - E 54% (I 11%, 39 cases.); The whole body - E 44% (I 13%, 200 cases.)
  •  40%+6%237 read Causticum hahnemanni
    Diseases - E 35% (I 1%, 237 cases.); Dependence - E 29% (I -1%, 23 cases.); Superficial - E 53% (I 17%, 25 cases.); The whole body - E 42% (I 5%, 100 cases.)
  •  39%+5%38 read Dulcamara
    Diseases - E 43% (I -6%, 38 cases.); Dependence - E 42% (I 10%, 5 cases.); The whole body - E 32% (I 10%, 18 cases.)
  •  39%+15%38 read Plumbum metallicum
    Diseases - E 29% (I 8%, 38 cases.); The whole body - E 49% (I 21%, 8 cases.)
  •  38%+6%137 read Ignatia amara
    Diseases - E 33% (I 4%, 137 cases.); Dependence - E 15% (I -14%, 20 cases.); Superficial - E 65% (I 24%, 10 cases.); The whole body - E 39% (I 8%, 44 cases.)
  •  37%+7%127 read Calcarea phosphorica
    Diseases - E 47% (I 9%, 127 cases.); Dependence - E 16% (I -3%, 15 cases.); Superficial - E 29% (I 5%, 13 cases.); The whole body - E 54% (I 17%, 57 cases.)
  •  36%-1%43 read Phosphoricum acidum
    Diseases - E 33% (I -1%, 43 cases.); Dependence - E 16% (I -25%, 5 cases.); The whole body - E 59% (I 23%, 17 cases.)
  •  34%+14%22 read Cuprum metallicum
    Diseases - E 34% (I 12%, 22 cases.); The whole body - E 33% (I 15%, 10 cases.)
  •  34%+3%570 read Sulphur
    Diseases - E 32% (I 5%, 570 cases.); Dependence - E 20% (I -2%, 59 cases.); Superficial - E 42% (I 3%, 80 cases.); The whole body - E 40% (I 6%, 184 cases.)
  •  33%+6%94 read Mercurius solubilis
    Diseases - E 30% (I 1%, 94 cases.); Dependence - E 23% (I -1%, 5 cases.); Superficial - E 34% (I 9%, 14 cases.); The whole body - E 45% (I 12%, 41 cases.)
  •  31%-7%27 read Aurum metallicum
    Diseases - E 49% (I 2%, 27 cases.); Dependence - E -7% (I -41%, 6 cases.); The whole body - E 50% (I 18%, 14 cases.)
  •  30%-31%18 read Nux moschata
  •  29%+12%93 read Carbo vegetabilis
    Diseases - E 37% (I 14%, 93 cases.); Dependence - E 15% (I 26%, 10 cases.); Superficial - E 25% (I 2%, 11 cases.); The whole body - E 39% (I 3%, 33 cases.)
  •  28%+19%13 read Tarentula hispanica
    Diseases - E 24% (I 18%, 13 cases.); The whole body - E 31% (I 20%, 6 cases.)
  •  28%+1%352 read Calcarea carbonica
    Diseases - E 30% (I 4%, 352 cases.); Dependence - E 23% (I 0%, 36 cases.); Superficial - E 30% (I 1%, 55 cases.); The whole body - E 29% (I -1%, 108 cases.)
  •  27%-2%28 read Agaricus muscarius
    Diseases - E 22% (I -2%, 28 cases.); The whole body - E 31% (I -2%, 9 cases.)
  •  10%-8%7 read Lithium carbonicum
    Diseases - E 25% (I 12%, 6 cases.); The whole body - E -5% (I -29%, 7 cases.)
  •  Adrenalinum read
  •  Aesculus hippocastanum read
  •  Antimonium arsenicosum read
  •  Chloralum hydratum read
  •  Cutis compositum read
  •  Elaterium officinarum read
  •  Hippozaeninum read
  •  Magnetis poli ambo read
  •  Malandrinum read
  •  Moschus moschiferus read
  •  Naphthalinum read
  •  Oleum animale aethereum dippeli read
  •  Piscidia erythrina read
  •  Tellurium read
  •  Trillium pendulum read
  •  Vaccininum read
  •  X-rays read
  •  Methysergidum read

Tree of ICD-10 diagnoses

  1. Description
  2. Similar diseases
  3. Related clinical guidelines
  4. Related standards of medical care
  5. Basic medical services
  6. Clinics for treatment

Other names and synonyms

T32.

Description

There is no detailed description, see related

Similar diseases

Related clinical guidelines

Related standards of medical care

42a96bb5c8a2acfb07fc866444b97bf1
✘Available only when using PRO account
Content moderator: Vasin A. S.


  1. Kiberis is NOT an online store and does NOT purchase, store, sell or deliver drugs. The resource acts only as an intermediary between you and the manufacturer of drugs or pharmacy points, which carry out the delivery.
  2. On Kiberis there are descriptions of drugs, some of which are intended only for doctors. This information cannot be used by patients to make decisions about the use of drugs, their cancellation or correction of dosages.
  3. Nothing in the information provided should be interpreted as a call to use these drugs.
  4. No claims can be made to Kiberis regarding any damage or harm incurred as a result of the use of the information posted on the site.